fda removes semaglutide from shortage list Novo's Wegovy and Ozempic removed US list, compounders on notice Whole Body Journal - Evidence-Based

Week 5 8: Significant Changes Begin Tirzepatide results per week begin to show more clearly, with average losses of 1-3 pounds per week

Many users prefer to start conservatively and adjust only if needed based on response and protocol design

Most patients report feeling the medication's effects most clearly about two to three days after their weekly injection

F.FiorentinoS

The path to UK approval typically follows a predictable pattern

April 4 Product: Basilea Pharmaceutica Zevtera Indication: Staphylococcus aureus bloodstream infections and community-acquired bacterial pneumonia Fifteen years of persistence paid off for Basilea Pharmaceutica on Thursday, as the FDA approved its antibiotic Zevtera for adults with Staphylococcus aureus bloodstream infections and adult and pediatric patients three months to less than 18 years old with community-acquired bacterial pneumonia